comparemela.com

Latest Breaking News On - Biotechnology trading down - Page 5 : comparemela.com

Vanguard Capital Wealth Advisors Acquires 52,500 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT)

Vanguard Capital Wealth Advisors increased its holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 228.3% during the 1st quarter, Holdings Channel reports. The firm owned 75,500 shares of the company’s stock after buying an additional 52,500 shares during the period. Vanguard Capital Wealth Advisors’ holdings in Nautilus Biotechnology were worth $209,000 at the […]

Nasdaq
Nautilus-biotechnology-inc
Citigroup-inc
Holdings-channel
Prelude-capital-management
Shay-capital
Vanguard-capital-wealth-advisors
Nautilus-biotechnology
Free-report
Capital-wealth-advisor
Capital-management

Lixte Biotechnology (NASDAQ:LIXT) Stock Price Up 15.6%

Shares of Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Free Report) rose 15.6% during trading on Tuesday . The stock traded as high as $7.00 and last traded at $6.01. Approximately 305,545 shares traded hands during mid-day trading, an increase of 294% from the average daily volume of 77,471 shares. The stock had previously closed at […]

Geode-capital-management
Ep-wealth-advisors
Ethos-financial-group
Lixte-biotechnology-holdings-inc
Nasdaq
Renaissance-technologies
Lixte-biotechnology-holdings
Free-report
Biotechnology-trading-down
Financial-group
Lixte-biotechnology

Puma Biotechnology (NASDAQ:PBYI) Upgraded to Buy by StockNews.com

StockNews.com upgraded shares of Puma Biotechnology (NASDAQ:PBYI – Get Rating) from a hold rating to a buy rating in a research note released on Tuesday. Separately, HC Wainwright reissued a buy rating and issued a $8.00 price objective on shares of Puma Biotechnology in a report on Monday, March 6th. Puma Biotechnology Trading Down 0.8 […]

Troy-edward-wilson
Hermes-inc
Prospera-financial-services-inc
Securities-exchange-commission
Puma-biotechnology-inc
Prudential-financial-inc
Boothbay-fund-management
Puma-biotechnology
Get-rating
Biotechnology-trading-down
Director-troy-edward-wilson
Exchange-commission

Puma Biotechnology, Inc. (NASDAQ:PBYI) to Post Q1 2025 Earnings of $0.07 Per Share, Zacks Research Forecasts

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Rating) – Research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of Puma Biotechnology in a research note issued to investors on Wednesday, June 7th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical company will earn $0.07 per share for the […]

Nasdaq
Puma-biotechnology-inc
Zacks-research
Affinity-asset-advisors
Cubist-systematic-strategies
Geode-capital-management
Boothbay-fund-management
Puma-biotechnology
Get-rating
Biotechnology-trading-down
Capital-management

Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Sells $141,982.04 in Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 5,197 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $27.32, for a total value of $141,982.04. Following the sale, the insider now owns 17,139,023 shares in the company, […]

Canada
China
Alaska
United-states
Jpmorgan-chase-co
Needham-company
Securities-exchange-commission
Vir-biotechnology-inc
Commonwealth-equity-services
Royal-bank
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.